MOCA: Digital vs. Speculum Exams for PPROM

Sponsor
Washington University School of Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05773014
Collaborator
(none)
86
2
21.2

Study Details

Study Description

Brief Summary

After preterm prelabor rupture of membranes (PPROM)[breaking of the amniotic sac prior to 37 weeks gestation in pregnancy], patients are recommended for inpatient admission and close monitoring for complications including preterm labor, intraamniotic infection (infection of the sac around the baby), and placental abruption (separation of the placenta from wall of the uterus). When evaluation of cervical dilation is clinically indicated, obstetricians traditionally perform sterile speculum exams due to concern for decrease in pregnancy latency (length of time between breaking the water and delivery) with sterile digital exams in retrospective studies. These studies are concerning, however, by the indications for the exams and are at risk for confounding by indication. This is a randomized, non-inferiority trial to examine if sterile digital versus speculum exams effect latency of pregnancy in patients with PPROM.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Speculum Exams
  • Procedure: Digital Exams
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
86 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Digital Versus Speculum Exams in Preterm Prelabor Rupture of Membranes: A Randomized Controlled Trial
Anticipated Study Start Date :
Mar 27, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Speculum Exams

If a patient requires cervical evaluation after PPROM, their cervix will be evaluated with a sterile speculum exam. A sterile speculum with lubricating jelly will be inserted into the patient's vagina to visualize the cervix and visually estimate cervical dilation and effacement.

Procedure: Speculum Exams
Same as arm

Active Comparator: Digital Exams

If a patient requires cervical evaluation after PPROM, their cervix will be evaluated with a digital exam. The provider will wear sterile gloves with lubricating jelly and will palpate the cervix to assess cervical dilation, effacement, and station.

Procedure: Digital Exams
Same as arm

Outcome Measures

Primary Outcome Measures

  1. Pregnancy latency [up to 10 weeks]

    time from admission to delivery

Secondary Outcome Measures

  1. Maternal chorioamnionitis [Prior to delivery]

    Per criteria of American College of Obstetricians and Gynecologists (ACOG): includes fever greater than or equal to 100.4 degrees Farenheit plus an additional sign such as fundal tenderness, white blood cell count >15, purulent vaginal discharge, fetal tachycardia, or placental culture with finding of chorioamnionitis. Suspected chorioamnionitis can also be diagnosed with isolated fever >102.2 degrees Fahrenheit

  2. Endomyometritis [Within 2 weeks of delivery]

    Clinical diagnosis of uterine infection after delivery, typically with fever and fundal tenderness

  3. Maternal sepsis [Within 2 weeks of delivery]

    Defined as bacteremia with evidence of organ dysfunction

  4. Maternal wound infections [Within 2 weeks of delivery]

    As diagnosed by the clinicians

  5. Maternal intensive care unit (ICU) admission [Within 2 weeks of delivery]

    transfer to ICU or readmission to ICU

  6. Maternal death [Within 2 weeks postpartum]

    Death of mother

  7. Composite neonatal morbidity [28 days of life]

    Need for respiratory support, neonatal sepsis, intraventricular hemorrhage, hypoxic ischemic encephalopathy, necrotizing enterocolitis, pneumonia, or neonatal demise

  8. Length of neonatal intensive care unit (NICU) admission [Up to 1 year]

    From delivery until discharge from the NICU

  9. Need for respiratory support [28 days of life]

    One or more of the following: Continuous positive airway pressure (CPAP) or high-flow nasal cannula for at least 2 consecutive hours, supplemental oxygen with a fraction of inspired oxygen of at least 0.30 for at least 4 continuous hours, extracorporeal membrane oxygenation (ECMO), or mechanical ventilation

  10. Neonatal sepsis at <72 hours of life [Within 72 hours of birth]

    must be confirmed on blood culture

  11. Neonatal sepsis at >72 hours of life [28 days of life]

    must be confirmed on blood culture

  12. Neonatal intraventricular hemorrhage (IVH) [28 days of life]

    Seen on head ultrasound

  13. Necrotizing enterocolitis (NEC) [28 days of life]

    As diagnosed by NICU team

  14. Hypoxic ischemic encephalopathy [28 days of life]

    As diagnosed by NICU team

  15. Neonatal pneumonia [28 days of life]

    As diagnosed by NICU team

  16. Neonatal death [During NICU admission, up to 1 year]

    As documented in the EMR

  17. Patient satisfaction with exams [At delivery]

    Survey regarding their experience with cervical exams

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 24 weeks 0 days gestation to 33 weeks 5 days gestation

  • Clinical or laboratory confirmation of PPROM

  • At least 8 hours and less than 72 hours of clinical stability after rupture event

  • English speaking

Exclusion Criteria:
  • multiple gestations

  • fetal surgery with entry into the amniotic sac this pregnancy

  • contraindications to digital examination

  • COVID-19 positive on admission

  • patients who received greater than one digital exam prior to enrollment

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Washington University School of Medicine

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT05773014
Other Study ID Numbers:
  • 202301012
First Posted:
Mar 17, 2023
Last Update Posted:
Mar 17, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Washington University School of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2023